Tradeweb Markets to Acquire Trumid for $1.97 Billion

Event Overview

On October 19, 2026, Tradeweb Markets LLC (a subsidiary of Tradeweb Markets Inc., NASDAQ: TW) entered into an Equity Purchase Agreement and Agreement and Plan of Merger to acquire all issued and outstanding equity interests of Trumid Holdings, LLC and its associated blocker entities.

Key Transaction Terms

• Total Purchase Price: $1.970 billion
  • Cash Consideration: $1.888 billion (subject to customary adjustments for cash, debt, working capital, and transaction expenses).
  • Equity Consideration: $82.0 million, satisfied via the issuance of 733,900 common membership units of Tradeweb Markets LLC and 733,900 shares of Class C common stock of Tradeweb Markets Inc. at par value ($0.00001 per share) to Trumid rollover holders.
• Exchange Mechanism: The issued LLC units are redeemable/exchangeable on a 1-for-1 basis for Class A common stock of Tradeweb Markets Inc. (or cash at Tradeweb's option), subject to transfer restrictions.
• Termination Fee: If the agreement is terminated under certain specified regulatory or antitrust circumstances, Tradeweb may be required to pay Trumid a termination fee of $105 million.
• Expected Closing: First half of 2027, subject to an outside date of October 19, 2027 (extendable up to 24 months from signing).

Required Approvals and Closing Conditions

• Hart-Scott-Rodino (HSR) Antitrust Improvements Act clearance.
• Competition and Markets Authority (CMA) review/clearance in the United Kingdom.
• Approval from the Financial Industry Regulatory Authority (FINRA).
• Notice to the Swiss Financial Market Supervisory Authority (FINMA).
• Customary representations, warranties, and absence of a Material Adverse Effect.

Strategic and Market Context

This transaction represents a major expansion of Tradeweb's electronic credit trading footprint, combining Trumid's corporate bond trading ecosystem and client network with Tradeweb's multi-asset trading platform. Financing will heavily rely on cash, complemented by rollover equity alignment for Trumid management.